antibacterial/neoplasms

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an anti-viral, anti-bacterial and anti-cancer agent, containing an alkaline extract of Aspalathus linearis belonging to the Leguminosae family, as the effective component. 2. Background Information Numerous

The present invention relates to novel mitomycin derivatives having antibacterial and anti-tumour activities. Mitomycins are generally known as antibiotics having antibacterial and anti-tumour activities. For example, mitomycin A, mitomycin B, mitomycin C and porfiromycin are descried in Merck

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to compounds and methods for obtaining such compounds in the fields of chemistry and medicine. More specifically, the present invention relates to compounds and procedures for making compounds useful in the treatment

BACKGROUND OF THE INVENTION The invention relates to methods of reducing cancer cell proliferation in biological systems. More specifically, the invention relates to the inhibition of solid tumor invasiveness and metastasis in mammals. Cancer, in all of its myriad manifestations, remains a

BACKGROUND OF THE INVENTION The invention relates to methods of reducing cancer growth in biological systems. More specifically, the invention relates to the inhibition of solid tumor invasiveness and metastasis in mammals. Cancer, in all of its myriad manifestations, remains a devastating scourge

TECHNICAL FIELD The invention relates to pharmaceutical compositions comprising certain Purine Nucleoside Phosphorylase (PNP) inhibitors and/or agents identified as endogenous adjuvants, which provide antiviral, antibacterial and anticancer effects and which provide an immunopotentiating effect when

SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Oct. 10, 2014, is named 2206057.00125US1_SL.txt and is 12,051 bytes in size. FIELD OF THE

The present invention relates to compounds hereinafter collectively designated UCF1, derivatives thereof and processes for their preparation. The compounds and derivatives of the present invention exhibit anti-bacterial and anti-tumour activities and may be used for the preparation of anti-bacterial

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to anti-viral and anti-tumor peptides and polypeptides. 2. Description of the Related Art The transmission of HIV type 1 (HIV-1) from mother to fetus is rare during the first trimester of pregnancy when the secretion

BACKGROUND 1. Field of the Invention The teachings provided herein are generally directed to methods of isolating and using a whole-saliva leech extract in the treatment of a subject. 2. Description of the Related Art The history of humans using leeches goes back several thousands of years, and

BACKGROUND 1. Field of the Invention The teachings provided herein are generally directed to methods of isolating and using a whole-saliva leech extract in the treatment of a subject. 2. Description of the Related Art The history of humans using leeches goes back several thousands of years, and

BACKGROUND 1. Field of the Invention The teachings provided herein are generally directed to methods of isolating and using a whole-saliva leech extract in the treatment of a subject. 2. Description of the Related Art The history of humans using leeches goes back several thousands of years, and

BACKGROUND 1. Field of the Invention The teachings provided herein are generally directed to methods of isolating and using a whole-saliva leech extract in the treatment of a subject. 2. Description of the Related Art The history of humans using leeches goes back several thousands of years, and

BACKGROUND 1. Field of the Invention The teachings provided herein are generally directed to methods of isolating and using a whole-saliva leech extract in the treatment of a subject. 2. Description of the Related Art The history of humans using leeches goes back several thousands of years, and

BACKGROUND OF THE INVENTION The present invention relates to therapeutic uses of bactericidal/permeability increasing (BPI) protein products for the treatment of conditions related to gram-negative bacterial infection and the conditions not directly associated with gram-negative bacterial infection,